Steward Partners Investment Advisory’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$275K Buy
3,508
+2,040
+139% +$139K ﹤0.01% 2051
2026
Q1
$94.9K Buy
1,468
+1,215
+480% +$85.7K ﹤0.01% 2395
2025
Q4
$17K Sell
253
-62
-20% -$4.17K ﹤0.01% 3199
2025
Q3
$23.1K Buy
315
+71
+29% +$4.72K ﹤0.01% 3026
2025
Q2
$12.7K Sell
244
-300
-55% -$17.1K ﹤0.01% 3108
2025
Q1
$34.7K Buy
544
+44
+9% +$2.56K ﹤0.01% 2557
2024
Q4
$23.9K Sell
500
-13
-3% -$667 ﹤0.01% 2693
2024
Q3
$29.4K Buy
513
+200
+64% +$11.5K ﹤0.01% 2479
2024
Q2
$16.4K Buy
313
+13
+4% +$570 ﹤0.01% 2604
2024
Q1
$12.2K Hold
300
– – ﹤0.01% 2734
2023
Q4
$11.1K Hold
300
– – ﹤0.01% 2664
2023
Q3
$11.5K Hold
300
– – ﹤0.01% 2542
2023
Q2
$10.8K Hold
300
– – ﹤0.01% 2544
2023
Q1
$11.5K Sell
300
-1,000
-77% -$46.9K ﹤0.01% 2494
2022
Q4
$74K Hold
1,300
– – ﹤0.01% 1672
2022
Q3
$51K Hold
1,300
– – ﹤0.01% 1772
2022
Q2
$57K Buy
+1,300
New +$56.2K ﹤0.01% 1740
2021
Q4
– Sell
-350
Closed -$14K – 3233
2021
Q3
$14K Hold
350
– – ﹤0.01% 2474
2021
Q2
$16K Sell
350
-500
-59% -$22.1K ﹤0.01% 5392
2021
Q1
$35.4K Buy
850
+500
+143% +$22.8K ﹤0.01% 2173
2020
Q4
$15K Buy
+350
New +$12.6K ﹤0.01% 2159
2020
Q1
– Sell
-2,400
Closed -$42K – 2584
2019
Q4
$42K Hold
2,400
– – ﹤0.01% 1475
2019
Q3
$37K Sell
2,400
-475
-17% -$7.82K ﹤0.01% 1485
2019
Q2
$49K Buy
+2,875
New +$46.4K ﹤0.01% 1342
2018
Q4
– Sell
-3,130
Closed -$57K – 1337
2018
Q3
$57K Sell
3,130
-10
-0.3% -$175 ﹤0.01% 1149
2018
Q2
$53K Buy
+3,140
New +$59.4K ﹤0.01% 1083

Other funds holding HALO

Steward Partners Investment Advisory's HALO Position: Q2 2026 in Review

Steward Partners Investment Advisory increased its Halozyme (HALO) stake by 139% in Q2 2026, buying an estimated $139K and bringing the position to 3,508 shares worth $275K. The position accounts for ﹤0.01% of the portfolio, ranked #2051.

Steward Partners Investment Advisory first reported a position in HALO in Q2 2018 and has held it in 26 quarters since. 675 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Steward Partners Investment Advisory held 3,508 shares of Halozyme worth $275K as of Q2 2026.
  • Steward Partners Investment Advisory bought 2,040 Halozyme shares in Q2 2026, an estimated $139K.
  • Halozyme made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #2051 holding.
  • Steward Partners Investment Advisory first reported a position in Halozyme in Q2 2018 and has held it in 26 quarters since.
  • 675 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.